Investment in Enalare Therapeutics Inc. (Tables)

6 Months Ended

Jun. 30, 2023

Equity Method Investments and Joint Ventures [Abstract]

Schedule of equity method investments

Summarized financial information of our investment and equity ownership in Enalare for the six months ending June 30, 2023 is presented below:

	Beginning balance as of December 31, 2022		Fair Value Adjustment		Additions / Adjustments during period		Ending balance as of June 30, 2023
Non-RDFV Investment (Other assets)	$	8,438	$	—	$	8,514	$	16,952
Acquisition Rights (Other assets)	8,125		—		—		8,125
Forward Liability (Accrued expenses and other liabilities)	(4,063)		77		3,986		—
Total, net	$	12,500	$	77	$	12,500	$	25,077